Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
44 /100
COMPONENT-LIMITED
Score updated Oct 27, 2026

KLRA — Kailera Therapeutics, Inc. Dilution Risk Tracker

Track KLRA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KLRA — Get alerts when the score changes →

As of October 27, 2026, Kailera Therapeutics, Inc. (KLRA) has a DilutionWatch DilutionScore of 44/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Kailera Therapeutics, Inc. has a market capitalization of $1.65B, 129.64M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊Float Risk—
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for KLRA.
🔔 Track KLRA — Get forecast alerts →

Market Data

Market Cap$1.65B
Shares Outstanding129.64M
FloatN/A
Cash$916.74M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore44/100DilutionWatch score record
Shares Outstanding129.64MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$1.65BMarket data cache
Cash Runway37.7 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

KLRA SEC Filing Activity — Last 12 Months

Shares outstanding reported by KLRA on the cover page of its latest 10-K/10-Q: 129.64M as of August 06, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for KLRA in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
10-Qquarterly report1Aug 12, 2026
SC 13Gpassive >5% holder filing2Aug 14, 2026
4insider transaction3Sep 09, 2026
3initial insider ownership2Sep 09, 2026

Institutional Holdings

39.8% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track KLRA for full holder detail →

Short Interest

Short Interest8.32M
Days to Cover5.7
% of FloatN/A
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-08-12
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual KLRA Dilution Snapshot

Kailera Therapeutics, Inc. (KLRA) has a DilutionScore of 44/100, rated Medium dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

KLRA's DilutionScore is currently 44/100 (Medium risk), with 3 score changes tracked over 89 days. The score deteriorated from 45/100 (Medium risk).

Period Score Risk Level Duration
Oct 19 – Oct 27, 202644/100MEDIUM9 days
Oct 14 – Oct 18, 202645/100MEDIUM5 days
Oct 09 – Oct 13, 202652/100HIGH5 days
Jul 30 – Oct 08, 202645/100MEDIUM70 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

KLRA shares outstanding have increased 9.8% from 117.95M (Apr 2026) to 129.54M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 03, 2026129.54M8.7K▼ 21.75%
May 02, 2026129.54M11.1K▲ 35.48%
Apr 26, 2026129.54M8.2K▼ 15.82%
Apr 22, 2026129.54M9.7K▲ 4.91%
Apr 20, 2026117.95M9.3K▼ 51.43%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track KLRA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment KLRA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking KLRA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note